Therefore, our cellular model of seeded tau aggregation using biochemically and ultrastructurally well-characterized pathogenic tau seeds derived from human tauopathies is expected to be useful as a prion-like propagation model that mimics the pathogenesis of sporadic tauopathy. The gene discussed is MAPT; the disease is tauopathy.